QuidelOrtho Corp (QDEL)
37.89
+0.41
(+1.09%)
USD |
NASDAQ |
Nov 21, 16:00
37.91
+0.02
(+0.05%)
Pre-Market: 20:00
QuidelOrtho Revenue (Quarterly): 727.10M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 727.10M |
| June 30, 2024 | 637.00M |
| March 31, 2024 | 711.00M |
| December 31, 2023 | 742.60M |
| September 30, 2023 | 744.00M |
| June 30, 2023 | 665.10M |
| March 31, 2023 | 846.10M |
| December 31, 2022 | 866.50M |
| September 30, 2022 | 783.80M |
| June 30, 2022 | 613.40M |
| March 31, 2022 | 1.002B |
| December 31, 2021 | 636.90M |
| September 30, 2021 | 509.80M |
| June 30, 2021 | 176.60M |
| March 31, 2021 | 375.34M |
| December 31, 2020 | 809.20M |
| September 30, 2020 | 476.06M |
| June 30, 2020 | 201.75M |
| March 31, 2020 | 174.65M |
| December 31, 2019 | 152.18M |
| September 30, 2019 | 126.49M |
| June 30, 2019 | 108.25M |
| March 31, 2019 | 147.97M |
| December 31, 2018 | 132.59M |
| September 30, 2018 | 117.40M |
| Date | Value |
|---|---|
| June 30, 2018 | 103.16M |
| March 31, 2018 | 169.14M |
| December 31, 2017 | 114.89M |
| September 30, 2017 | 50.89M |
| June 30, 2017 | 38.27M |
| March 31, 2017 | 73.69M |
| December 31, 2016 | 52.81M |
| September 30, 2016 | 49.34M |
| June 30, 2016 | 39.13M |
| March 31, 2016 | 50.32M |
| December 31, 2015 | 52.41M |
| September 30, 2015 | 46.81M |
| June 30, 2015 | 35.20M |
| March 31, 2015 | 61.70M |
| December 31, 2014 | 63.95M |
| September 30, 2014 | 41.19M |
| June 30, 2014 | 31.49M |
| March 31, 2014 | 46.67M |
| December 31, 2013 | 52.08M |
| September 30, 2013 | 33.54M |
| June 30, 2013 | 29.71M |
| March 31, 2013 | 62.00M |
| December 31, 2012 | 53.92M |
| September 30, 2012 | 33.00M |
| June 30, 2012 | 30.86M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
152.18M
Minimum
Dec 2019
1.002B
Maximum
Mar 2022
592.57M
Average
651.05M
Median
Revenue (Quarterly) Benchmarks
| Abbott Laboratories | 10.64B |
| Becton Dickinson & Co | 5.437B |
| Repligen Corp | 154.87M |
| Perspective Therapeutics Inc | -- |
| Xtant Medical Holdings Inc | 27.94M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -19.90M |
| Total Expenses (Quarterly) | 675.30M |
| EPS Diluted (Quarterly) | -0.30 |
| Enterprise Value | 4.955B |
| Gross Profit Margin (Quarterly) | 48.45% |
| Profit Margin (Quarterly) | -2.74% |
| Earnings Yield | -73.63% |
| Operating Earnings Yield | 3.96% |
| Normalized Earnings Yield | -3.500 |